Cargando…
Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes
Transfer of autologous tumor infiltrating lymphocytes (TIL) to patients with refractory melanoma has shown clinical efficacy in a number of trials. However, extending the clinical benefit to patients with other cancers poses a challenge. Inefficient costimulation in the tumor microenvironment can le...
Autores principales: | Kalaitsidou, Milena, Moon, Owen R., Sykorova, Martina, Bao, Leyuan, Qu, Yun, Sukumaran, Sujita, Valentine, Michael, Zhou, Xingliang, Pandey, Veethika, Foos, Kay, Medvedev, Sergey, Powell Jr, Daniel J., Udyavar, Akshata, Gschweng, Eric, Rodriguez, Ruben, Dudley, Mark E., Hawkins, Robert E., Kueberuwa, Gray, Bridgeman, John S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664248/ https://www.ncbi.nlm.nih.gov/pubmed/38022678 http://dx.doi.org/10.3389/fimmu.2023.1256491 |
Ejemplares similares
-
CD43 is a murine T cell costimulatory receptor that functions independently of CD28
Publicado: (1995) -
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
por: Kueberuwa, Gray, et al.
Publicado: (2018) -
CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity
por: Kueberuwa, Gray, et al.
Publicado: (2017) -
CD95 as a negative or positive costimulatory receptor for primary T cell activation
por: Paulsen, M, et al.
Publicado: (2009) -
The Purinergic System and Glial Cells: Emerging Costars in Nociception
por: Magni, Giulia, et al.
Publicado: (2014)